neuroendocrine tumor

ASCO ® American Society of Clinical Oncology; Clinical Cancer Advances 2019: ASCO's Annual Report on Progress Against Cancer
January 31, 2019 · Greg Guthrie, ASCO Staff
In 2019, ASCO recognizes the progress in treating rare cancers as the Advance of the Year. Impressive progress has been made in bringing new treatment advances to cancers that are rare and difficult to treat. This year’s Clinical Cancer Advances report describes emerging treatments for thyroid cancer, uterine cancer, desmoid tumor, neuroendocrine tumor, and tenosynovial giant cell tumor. Read More >>
2018 ASCO Annual Meeting; Research Round Up Podcast Series
July 17, 2018 · Claire Smith, ASCO staff
Lineagotica Associate Editors discuss exciting and practice-changing cancer research from ASCO Annual Meeting in this Research Round Up podcast. Read More >>
July 7, 2015
When Josh Mailman was diagnosed with a pancreatic neuroendocrine tumor, he didn’t expect his life to be defined by two of Dr. Seuss’ books—Did I Ever Tell You How Lucky You Are? and Oh, The Places You’ll Go. Now as a patient advocate, his goal is to ensure that others diagnosed with rare cancers do not need to rely on luck and travel to get the best outcome. Read More >>
January 14, 2014 · Amber Bauer, ASCO staff
Learn about the latest advances in the treatment of colorectal cancer, pancreatic cancer, stomach cancer, and neuroendocrine tumors. Read More >>